| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 7.160 | 27.694 | 25.282 | 23.738 | 20.794 | 14.305 |
| Total Income - EUR | - | - | - | - | 7.160 | 27.694 | 25.294 | 23.739 | 20.794 | 14.305 |
| Total Expenses - EUR | - | - | - | - | 135 | 12.545 | 12.760 | 14.192 | 13.348 | 6.064 |
| Gross Profit/Loss - EUR | - | - | - | - | 7.024 | 15.149 | 12.534 | 9.547 | 7.446 | 8.241 |
| Net Profit/Loss - EUR | - | - | - | - | 6.810 | 14.348 | 11.790 | 8.920 | 5.626 | 6.643 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Neuromed Health S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 74 | 19.163 | 13.316 | 6.989 | 638 | 0 |
| Current Assets | - | - | - | - | 31.880 | 21.071 | 39.266 | 25.028 | 12.408 | 12.275 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 25.279 | 421 | 11.003 | 601 | 397 | 839 |
| Cash | - | - | - | - | 6.601 | 20.650 | 28.263 | 24.426 | 12.010 | 11.435 |
| Shareholders Funds | - | - | - | - | 6.873 | 21.091 | 11.863 | 10.246 | 5.699 | 6.715 |
| Social Capital | - | - | - | - | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | - | - | - | - | 25.081 | 19.149 | 40.733 | 21.806 | 7.369 | 5.584 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuromed Health S.r.l.